{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:45:57Z","timestamp":1792799157630,"version":"4.5.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.clinre.2011.07.013","type":"journal-article","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T02:27:32Z","timestamp":1315621652000},"page":"110-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Urinary tract infection as a risk factor for autoimmune liver disease: From bench to bedside"],"prefix":"10.1016","volume":"36","author":[{"given":"Daniel S.","family":"Smyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Kriese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Billinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew K.","family":"Burroughs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini I.","family":"Rigopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2011.07.013_bib0005","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00281-009-0164-5","article-title":"Primary biliary cirrhosis","volume":"31","author":"Hohenester","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0010","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2011.07.013_bib0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0020","first-page":"112","article-title":"Infection and primary biliary cirrhosis","volume":"11","author":"Agmon-Levin","year":"2009","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.clinre.2011.07.013_bib0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jhep.2009.11.027","article-title":"Primary biliary cirrhosis: a 2010 update","volume":"52","author":"Poupon","year":"2010","journal-title":"J Hepatol"},{"issue":"Suppl. 1","key":"10.1016\/j.clinre.2011.07.013_bib0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-8278(00)80421-3","article-title":"Chronic cholestatic diseases","volume":"32","author":"Poupon","year":"2000","journal-title":"J Hepatol"},{"issue":"759\u201377","key":"10.1016\/j.clinre.2011.07.013_bib0035","article-title":"Antimitochondrial and other autoantibodies","volume":"7","author":"Bogdanos","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinre.2011.07.013_bib0040","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0045","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cca.2010.12.019","article-title":"Disease-specific autoantibodies in primary biliary cirrhosis","volume":"412","author":"Bogdanos","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"9081","key":"10.1016\/j.clinre.2011.07.013_bib0050","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(97)05419-6","article-title":"Primary biliary cirrhosis","volume":"350","author":"Neuberger","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2011.07.013_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-3-1","article-title":"Primary biliary cirrhosis","volume":"3","author":"Kumagi","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clinre.2011.07.013_bib0060","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/hep.21678","article-title":"Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis","volume":"45","author":"Bogdanos","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cca.2006.04.001","article-title":"Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen","volume":"373","author":"Bogdanos","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinre.2011.07.013_bib0070","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1572-0241.2004.04119.x","article-title":"Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain","volume":"99","author":"Bogdanos","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0075","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1373\/clinchem.2008.118299","article-title":"New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies","volume":"55","author":"Dahnrich","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinre.2011.07.013_bib0080","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10875-007-9092-0","article-title":"Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis","volume":"27","author":"Gabeta","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0085","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/0016-5085(91)80033-6","article-title":"Primary biliary cirrhosis: paradigm or paradox for autoimmunity","volume":"100","author":"Gershwin","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0090","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","article-title":"PBC screen: an IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis","volume":"35","author":"Liu","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2011.07.013_bib0095","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2011.07.013_bib0100","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.1840060609","article-title":"Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?","volume":"6","author":"Mitchison","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cca.2007.01.023","article-title":"Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis","volume":"380","author":"Rigopoulou","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinre.2011.07.013_bib0110","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/gut.2003.036558","article-title":"Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis","volume":"54","author":"Rigopoulou","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.07.013_bib0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1572-0241.2003.07270.x","article-title":"Positive markers in AMA-negative PBC","volume":"98","author":"Vergani","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0120","first-page":"1","article-title":"Primary biliary cirrhosis: family stories","volume":"11","author":"Smyk","year":"2011","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.clinre.2011.07.013_bib0125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-2007-1007183","article-title":"Antimitochondrial antibodies in primary biliary cirrhosis","volume":"17","author":"Leung","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2011.07.013_bib0130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1034\/j.1600-0528.2002.017410.x","article-title":"The peculiar autoimmunity of primary biliary cirrhosis","volume":"174","author":"Mackay","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.clinre.2011.07.013_bib0135","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1478-3231.2007.01586.x","article-title":"Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis","volume":"27","author":"Rigopoulou","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2011.07.013_bib0140","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.510290444","article-title":"Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression","volume":"29","author":"Degott","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0145","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/hep.22831","article-title":"Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol","volume":"50","author":"Kaplan","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000324139","article-title":"Treatment of primary biliary cirrhosis with ursodeoxycholic acid, budesonide and fibrates","volume":"29","author":"Poupon","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.clinre.2011.07.013_bib0155","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/bega.2000.0107","article-title":"Treatment of primary biliary cirrhosis","volume":"14","author":"Poupon","year":"2000","journal-title":"Baillieres Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0160","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.gcb.2010.02.004","article-title":"Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone","volume":"34","author":"Rabahi","year":"2010","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0165","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0170","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-0029-1233528","article-title":"Autoimmune hepatitis","volume":"29","author":"Manns","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2011.07.013_bib0175","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/MPG.0b013e3181a1c265","article-title":"Autoimmune hepatitis","volume":"49","author":"Mieli-Vergani","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2011.07.013_bib0180","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.3748\/wjg.14.3360","article-title":"Autoimmune paediatric liver disease","volume":"14","author":"Mieli-Vergani","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0185","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00281-009-0170-7","article-title":"Autoimmune hepatitis","volume":"31","author":"Vergani","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0190","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.3748\/wjg.14.3306","article-title":"Aetiopathogenesis of autoimmune hepatitis","volume":"14","author":"Vergani","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0195","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1233533","article-title":"Autoantibodies and their antigens in autoimmune hepatitis","volume":"29","author":"Bogdanos","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2011.07.013_bib0200","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1517\/14656566.2011.524206","article-title":"Pharmacological management of autoimmune hepatitis","volume":"12","author":"Vergani","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.clinre.2011.07.013_bib0205","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(03)15418-9","article-title":"Retrovirus infection as a trigger for primary biliary cirrhosis?","volume":"363","author":"Poupon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2011.07.013_bib0210","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2008.07.027","article-title":"Genetic factors of susceptibility and of severity in primary biliary cirrhosis","volume":"49","author":"Poupon","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0215","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-0031-1276644","article-title":"Progress in the genetics of primary biliary cirrhosis","volume":"31","author":"Hirschfield","year":"2011","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2011.07.013_bib0220","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.it.2009.05.006","article-title":"The role of environmental factors in primary biliary cirrhosis","volume":"30","author":"Selmi","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2011.07.013_bib0235","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.21123","article-title":"Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis","volume":"43","author":"Lan","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0240","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jhep.2010.02.019","article-title":"Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis","volume":"53","author":"Corpechot","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0245","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0250","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/jhep.2001.21165","article-title":"Risk factors for primary biliary cirrhosis in a cohort of patients from the United States","volume":"33","author":"Parikh-Patel","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0255","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/gut.2009.184218","article-title":"Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations","volume":"59","author":"Prince","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.07.013_bib0260","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1590-8658(03)00466-3","article-title":"Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection","volume":"35","author":"Bogdanos","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2011.07.013_bib0265","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-8278(03)00501-4","article-title":"Microbial mimics are major targets of cross-reactivity with human pyruvate dehydrogenase in primary biliary cirrhosis","volume":"40","author":"Bogdanos","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0270","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/00365520410003236","article-title":"Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter\u00a0pylori does not lead to immunological cross-reactivity","volume":"39","author":"Bogdanos","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0275","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0168-8278(01)00252-5","article-title":"Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis","volume":"36","author":"Bogdanos","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0280","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1155\/2010\/595078","article-title":"The role of E.\u00a0coli infection in the pathogenesis of primary biliary cirrhosis","volume":"29","author":"Bogdanos","year":"2010","journal-title":"Dis Markers"},{"key":"10.1016\/j.clinre.2011.07.013_bib0285","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1034\/j.1600-0676.2001.021004225.x","article-title":"Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences","volume":"21","author":"Bogdanos","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.clinre.2011.07.013_bib0290","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaut.2004.03.002","article-title":"Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium\u00a0gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis","volume":"22","author":"Bogdanos","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2011.07.013_bib0295","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12016-008-8087-9","article-title":"Bacteria and primary biliary cirrhosis","volume":"36","author":"Bogdanos","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0300","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1740-2557-1-4","article-title":"Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis","volume":"1","author":"Bogdanos","year":"2004","journal-title":"J Autoimmune Dis"},{"key":"10.1016\/j.clinre.2011.07.013_bib0305","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0925-4439(95)00017-X","article-title":"Mitochondrial antigens, molecular mimicry and autoimmune disease","volume":"1271","author":"Baum","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clinre.2011.07.013_bib0310","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/358377a0","article-title":"Molecular mimicry in liver disease","volume":"358","author":"Burroughs","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.clinre.2011.07.013_bib0315","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/gut.25.2.133","article-title":"Bacteriuria and primary biliary cirrhosis","volume":"25","author":"Burroughs","year":"1984","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.07.013_bib0320","first-page":"473","article-title":"Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis?","volume":"35","author":"Butler","year":"1995","journal-title":"Biochem Mol Biol Int"},{"key":"10.1016\/j.clinre.2011.07.013_bib0325","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/gut.36.6.931","article-title":"Natural history of bacteriuria in women with primary biliary cirrhosis and the effect of antimicrobial therapy in symptomatic and asymptomatic groups","volume":"36","author":"Butler","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.07.013_bib0330","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0168-8278(05)80225-9","article-title":"M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria","volume":"17","author":"Butler","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0335","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/1752-1947-4-311","article-title":"Autoimmune hepatitis triggered by nitrofurantoin: a case series","volume":"4","author":"Appleyard","year":"2010","journal-title":"J Med Case Reports"},{"key":"10.1016\/j.clinre.2011.07.013_bib0340","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0002-9343(79)90086-X","article-title":"Nitrofurantoin: another cause of drug-induced chronic active hepatitis? A report of a patient with HLA-B8 antigen","volume":"67","author":"Hatoff","year":"1979","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.clinre.2011.07.013_bib0345","first-page":"295","article-title":"Bacteriuria in primary biliary cirrhosis","volume":"185","author":"Barrios Alonso","year":"1989","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.clinre.2011.07.013_bib0350","first-page":"499","article-title":"Bacteriuria in patients with primary biliary cirrhosis","volume":"121","author":"Brahm","year":"1993","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.clinre.2011.07.013_bib0355","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2169\/internalmedicine.42.1144","article-title":"A patient with E.\u00a0coli-induced pyelonephritis and sepsis who transiently exhibited symptoms associated with primary biliary cirrhosis","volume":"42","author":"Ohno","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.clinre.2011.07.013_bib0360","first-page":"270","article-title":"A case of rapid-onset antimitochondrial antibody-positive autoimmune hepatitis possibly triggered by a urinary tract infection","volume":"107","author":"Kiriyama","year":"2010","journal-title":"Nippon Shokakibyo Gakkai Zasshi"},{"key":"10.1016\/j.clinre.2011.07.013_bib0365","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1872-034X.2011.00806.x","article-title":"Smoking, family history and urinary tract infection are associated with primary biliary cirrhosis: a meta-analysis","volume":"41","author":"Liang","year":"2011","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clinre.2011.07.013_bib0370","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1053\/he.2000.7050","article-title":"An exploratory population-based case-control study of primary biliary cirrhosis","volume":"31","author":"Howel","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0375","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.20788","article-title":"Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic","volume":"42","author":"Bogdanos","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0380","unstructured":"Bernier M, Njomnang Soh P, Lochet A, Prots L, Felice R, Senescau A, et al. Lactobacillus\u00a0delbrueckii: Probable agent of urinary tract infections in very old women. Pathol Biol (Paris) 2010. Jun 2. [Epub ahead of print] PMID: 20605373."},{"key":"10.1016\/j.clinre.2011.07.013_bib0385","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1128\/JCM.01630-08","article-title":"Lactobacillus\u00a0delbrueckii as the cause of urinary tract infection","volume":"47","author":"Darbro","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0390","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jhep.2008.05.022","article-title":"Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis","volume":"49","author":"Bogdanos","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0395","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2174\/1566524013363672","article-title":"Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity","volume":"1","author":"Wen","year":"2001","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.clinre.2011.07.013_bib0400","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/hep.20028","article-title":"Unusual suspects in primary biliary cirrhosis","volume":"39","author":"Vergani","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0405","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/jhep.2001.23902","article-title":"Molecular mimicry and primary biliary cirrhosis: premises not promises","volume":"33","author":"Van de Water","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0410","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0168-8278(89)90045-7","article-title":"Significant bacteriuria has prognostic significance in primary biliary cirrhosis","volume":"9","author":"Morreale","year":"1989","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0415","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1590-8658(00)80266-2","article-title":"Virus, liver and autoimmunity","volume":"32","author":"Bogdanos","year":"2000","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2011.07.013_bib0420","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1542-3565(05)00018-2","article-title":"Susceptibility to thyroid disorders in hepatitis C","volume":"3","author":"Muratori","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0425","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1089-3261(02)00018-1","article-title":"Pathogenesis of autoimmune hepatitis","volume":"6","author":"Vergani","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinre.2011.07.013_bib0430","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.crohns.2010.10.009","article-title":"Peculiar antibody reactivity to human connexin 37 and its microbial mimics in patients with Crohn's disease","volume":"5","author":"Koutsoumpas","year":"2011","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.clinre.2011.07.013_bib0435","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.gastro.2006.04.021","article-title":"Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?","volume":"131","author":"Polymeros","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0440","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2004.08.022","article-title":"Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis","volume":"41","author":"Alvaro","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0445","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1084\/jem.181.5.1835","article-title":"HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases","volume":"181","author":"Shimoda","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinre.2011.07.013_bib0450","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1053\/jhep.2000.8090","article-title":"Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis","volume":"31","author":"Shimoda","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0455","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1172\/JCI4213","article-title":"Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis","volume":"102","author":"Shimoda","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2011.07.013_bib0460","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1073\/pnas.87.10.3987","article-title":"Reactivity of primary biliary cirrhosis sera with Escherichia\u00a0coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region","volume":"87","author":"Fussey","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinre.2011.07.013_bib0465","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0014-5793(89)80251-0","article-title":"Characterisation of the reactivity of autoantibodies in primary biliary cirrhosis","volume":"246","author":"Fussey","year":"1989","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clinre.2011.07.013_bib0470","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1478-3231.2006.01291.x","article-title":"Origin of cross-reactive autoimmunity in primary biliary cirrhosis","volume":"26","author":"Bogdanos","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2011.07.013_bib0475","first-page":"289","article-title":"Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis","volume":"13","author":"Miyakawa","year":"2006","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0480","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0896-8411(03)00024-6","article-title":"Promiscuous T cells selected by Escherichia\u00a0coli: OGDC-E2 in primary biliary cirrhosis","volume":"20","author":"Tanimoto","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clinre.2011.07.013_bib0485","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0168-8278(01)00059-9","article-title":"Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope","volume":"34","author":"Baum","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0490","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0140-6736(89)92034-5","article-title":"Relation between Escherichia\u00a0coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis","volume":"2","author":"Hopf","year":"1989","journal-title":"Lancet"},{"issue":"4(Suppl. 1)","key":"10.1016\/j.clinre.2011.07.013_bib0495","first-page":"A837","article-title":"Recurrent urinary tract infection in mice results in immune-mediated cholangiopathy similar to human primary biliary cirrhosis","volume":"134","author":"Palermo","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0500","first-page":"217","article-title":"A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics","volume":"12","author":"Bogdanos","year":"2005","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0505","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2174\/092986708785747508","article-title":"Enzymes as target antigens of liver-specific autoimmunity: the case of cytochromes P450s","volume":"15","author":"Bogdanos","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.clinre.2011.07.013_bib0510","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4049\/jimmunol.169.1.277","article-title":"Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule","volume":"169","author":"Ma","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0515","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/ard.51.5.604","article-title":"Increased incidence of urinary tract infection in patients with rheumatoid arthritis and secondary Sjogren's syndrome","volume":"51","author":"Tishler","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2011.07.013_bib0520","first-page":"2406","article-title":"Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjogren's syndrome","volume":"30","author":"Walker","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0525","doi-asserted-by":"crossref","unstructured":"Varyani FK, West J, Card TR. An increased risk of urinary tract infection precedes development of primary biliary cirrhosis. BMC Gastroenterol, 2011;11:95, doi:10.1186\/1471-230X-11-95.","DOI":"10.1186\/1471-230X-11-95"},{"key":"10.1016\/j.clinre.2011.07.013_bib0530","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/art.24749","article-title":"Shared familial aggregation of susceptibility to autoimmune diseases","volume":"60","author":"Hemminki","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinre.2011.07.013_bib0535","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ng.631","article-title":"Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis","volume":"42","author":"Hirschfield","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinre.2011.07.013_bib0540","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2011.07.013_bib0545","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ng.627","article-title":"Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis","volume":"42","author":"Liu","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinre.2011.07.013_bib0550","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.789","article-title":"Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis","volume":"43","author":"Mells","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinre.2011.07.013_bib0555","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1399-0039.2011.01684.x","article-title":"Replicated association of 17q12-21 with susceptibility of primary biliary cirrhosis in a Japanese cohort","volume":"78","author":"Tanaka","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.clinre.2011.07.013_bib0560","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1399-0039.2010.01600.x","article-title":"Genetic association of Fc receptor-like 3 polymorphisms with susceptibility to primary biliary cirrhosis: ethnic comparative study in Japanese and Italian patients","volume":"77","author":"Tanaka","year":"2011","journal-title":"Tissue Antigens"},{"issue":"2","key":"10.1016\/j.clinre.2011.07.013_bib0650","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/hep.24414","article-title":"Human leukocyte antigen in primary biliary cirrhosis: an old story now reviving","volume":"54","author":"Invernizzi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0570","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/hep.22567","article-title":"Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls","volume":"48","author":"Invernizzi","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0575","first-page":"184","article-title":"Nitrofurantoin-induced chronic active hepatitis","volume":"4","author":"Amit","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.clinre.2011.07.013_bib0580","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.2008.058248","article-title":"Histological patterns in drug-induced liver disease","volume":"62","author":"Ramachandran","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0585","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840080327","article-title":"Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases","volume":"8","author":"Stricker","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0590","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bjornsson","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0595","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00004836-200609000-00018","article-title":"Autoimmune hepatitis triggered by statins","volume":"40","author":"Alla","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0600","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0609.1996.tb01652.x","article-title":"Anti-cytochrome P450 autoantibodies in drug-induced disease","volume":"60","author":"Beaune","year":"1996","journal-title":"Eur J Haematol Suppl"},{"key":"10.1016\/j.clinre.2011.07.013_bib0605","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1021\/tx960083q","article-title":"Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis","volume":"9","author":"Bourdi","year":"1996","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0610","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11739-009-0342-4","article-title":"Infliximab-related hepatitis: discussion of a case and review of the literature","volume":"5","author":"Mancini","year":"2010","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.clinre.2011.07.013_bib0615","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0940-2993(99)80027-X","article-title":"Influence of urethane and ketamine on rat hepatic cytochrome P450 in vivo","volume":"51","author":"Meneguz","year":"1999","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0620","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.4049\/jimmunol.174.9.5874","article-title":"Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid","volume":"174","author":"Amano","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0625","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.4049\/jimmunol.172.10.6444","article-title":"Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible","volume":"172","author":"Amano","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0630","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.22042","article-title":"The causes of primary biliary cirrhosis: convenient and inconvenient truths","volume":"47","author":"Gershwin","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0635","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/hep.1840120612","article-title":"Site-directed mutagenesis of lysine within the immunodominant autoepitope of PDC-E2","volume":"12","author":"Leung","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.013_bib0640","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.4049\/jimmunol.167.5.2956","article-title":"Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis","volume":"167","author":"Long","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.clinre.2011.07.013_bib0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cmi.2009.104","article-title":"Experimental evidence on the immunopathogenesis of primary biliary cirrhosis","volume":"7","author":"Selmi","year":"2010","journal-title":"Cell Mol Immunol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740111002592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740111002592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:14:02Z","timestamp":1761894842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740111002592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":129,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S2210740111002592"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2011.07.013","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary tract infection as a risk factor for autoimmune liver disease: From bench to bedside","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2011.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}